68 related articles for article (PubMed ID: 16539034)
1. Selective action of fluoroquinolones against intracellular amastigotes of Leishmania (Viannia) panamensis in vitro.
Romero IC; Saravia NG; Walker J
J Parasitol; 2005 Dec; 91(6):1474-9. PubMed ID: 16539034
[TBL] [Abstract][Full Text] [Related]
2. Leishmania panamensis: comparative inhibition of nuclear DNA topoisomerase II enzymes from promastigotes and human macrophages reveals anti-parasite selectivity of fluoroquinolones, flavonoids and pentamidine.
Cortázar TM; Coombs GH; Walker J
Exp Parasitol; 2007 Aug; 116(4):475-82. PubMed ID: 17466980
[TBL] [Abstract][Full Text] [Related]
3. Correlation of in vitro activities of the fluoroquinolones to their in vivo efficacies.
Fernandes PB; Swanson RN
Drugs Exp Clin Res; 1988; 14(6):375-8. PubMed ID: 3145851
[TBL] [Abstract][Full Text] [Related]
4. T cell-mediated hypersensitivity to quinolones: mechanisms and cross-reactivity.
Schmid DA; Depta JP; Pichler WJ
Clin Exp Allergy; 2006 Jan; 36(1):59-69. PubMed ID: 16393267
[TBL] [Abstract][Full Text] [Related]
5. Overview of the fluoroquinolone antibiotics.
Just PM
Pharmacotherapy; 1993; 13(2 Pt 2):4S-17S. PubMed ID: 8386356
[TBL] [Abstract][Full Text] [Related]
6. Induced and photoinduced DNA damage by quinolones: ciprofloxacin, ofloxacin and nalidixic acid determined by comet assay.
Sánchez G; Hidalgo ME; Vivanco JM; Escobar J
Photochem Photobiol; 2005; 81(4):819-22. PubMed ID: 15691228
[TBL] [Abstract][Full Text] [Related]
7. Corneal and scleral permeability of quinolones--a pharmacokinetics study.
Tai MC; Lu DW; Chiang CH
J Ocul Pharmacol Ther; 2003 Dec; 19(6):547-54. PubMed ID: 14733712
[TBL] [Abstract][Full Text] [Related]
8. Activity of fluoroquinolone antibiotics against Plasmodium falciparum in vitro.
Divo AA; Sartorelli AC; Patton CL; Bia FJ
Antimicrob Agents Chemother; 1988 Aug; 32(8):1182-6. PubMed ID: 2847647
[TBL] [Abstract][Full Text] [Related]
9. Comparative activity of quinolones (ciprofloxacin, levofloxacin, moxifloxacin and garenoxacin) against extracellular and intracellular infection by Listeria monocytogenes and Staphylococcus aureus in J774 macrophages.
Seral C; Barcia-Macay M; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F
J Antimicrob Chemother; 2005 Apr; 55(4):511-7. PubMed ID: 15731197
[TBL] [Abstract][Full Text] [Related]
10. [In vitro activity of seven gyrase inhibitors of a group of heterocyclic carbonic acids against nonfermenting gram negative rods (nonfermenters)].
Grimm H
Arzneimittelforschung; 1985; 35(3):570-2. PubMed ID: 2986655
[TBL] [Abstract][Full Text] [Related]
11. [Comparative in vitro activity of 10 new 4-quinolones against enteropathogenic bacteria].
Habiyaremye I; Verbist L; Vandepitte J
Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):800-4. PubMed ID: 3116489
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of lomefloxacin, a new difluorinated quinolone, against urinary bacterial isolates: comparison with enoxacin and ofloxacin.
Azadian BS; Talboys CA; Roberts AP
J Chemother; 1989 Jul; 1(4 Suppl):176-7. PubMed ID: 16312357
[No Abstract] [Full Text] [Related]
13. Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate.
Vouldoukis I; Rougier S; Dugas B; Pino P; Mazier D; Woehrlé F
Vet Parasitol; 2006 Jan; 135(2):137-46. PubMed ID: 16242844
[TBL] [Abstract][Full Text] [Related]
14. Comparative evaluation of antiproliferative activity and induction of apoptosis by some fluoroquinolones with a human non-small cell lung cancer cell line in culture.
Mondal ER; Das SK; Mukherjee P
Asian Pac J Cancer Prev; 2004; 5(2):196-204. PubMed ID: 15244525
[TBL] [Abstract][Full Text] [Related]
15. The fluoroquinolones for urinary tract infections: a review.
Cunha BA
Adv Ther; 1994; 11(6):277-96. PubMed ID: 10150268
[TBL] [Abstract][Full Text] [Related]
16. Photocleavage of DNA by the fluoroquinolone antibacterials.
Martínez L; Chignell CF
J Photochem Photobiol B; 1998 Aug; 45(1):51-9. PubMed ID: 9819899
[TBL] [Abstract][Full Text] [Related]
17. [Antibacterial activity of norfloxacin, ofloxacin and ciprofloxacin according to resistance phenotypes to nalidixic acid and pefloxacin].
Soussy CJ; Le Van Thoi J; Duval J
Pathol Biol (Paris); 1990 May; 38(5):376-84. PubMed ID: 2367152
[TBL] [Abstract][Full Text] [Related]
18. Comparison of serum bactericidal activity of 4 fluoroquinolones in healthy volunteers.
Wang R; Liu YN; Zhao HZ; Sun XD
Chin Med J (Engl); 1992 Jun; 105(6):500-5. PubMed ID: 1451552
[TBL] [Abstract][Full Text] [Related]
19. Comparative antimicrobial activity of lomefloxacin, norfloxacin, ofloxacin, ciprofloxacin and enoxacin against > 500 bacterial isolates.
Ismaeel NA; Tayeb OS
Microbios; 1993; 74(300):147-54. PubMed ID: 8396196
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of fluoroquinolones against chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum.
Tripathi KD; Sharma AK; Valecha N; Biswas S
Indian J Malariol; 1993 Jun; 30(2):67-73. PubMed ID: 8405596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
